171 related articles for article (PubMed ID: 32370743)
1. MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers.
Egeland NG; Jonsdottir K; Aure MR; Sahlberg K; Kristensen VN; Cronin-Fenton D; Skaland I; Gudlaugsson E; Baak JPA; Janssen EAM
BMC Cancer; 2020 May; 20(1):377. PubMed ID: 32370743
[TBL] [Abstract][Full Text] [Related]
2. Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.
Jonsdottir K; Janssen SR; Da Rosa FC; Gudlaugsson E; Skaland I; Baak JP; Janssen EA
PLoS One; 2012; 7(11):e48692. PubMed ID: 23144930
[TBL] [Abstract][Full Text] [Related]
3. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α regulates ATM Expression through miRNAs in breast cancer.
Guo X; Yang C; Qian X; Lei T; Li Y; Shen H; Fu L; Xu B
Clin Cancer Res; 2013 Sep; 19(18):4994-5002. PubMed ID: 23857602
[TBL] [Abstract][Full Text] [Related]
5. Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial-Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer.
Nair MG; Mavatkar AD; Naidu CM; V P S; C E A; Rajarajan S; Sahoo S; Mohan G; Jaikumar VS; Ramesh RS; B S S; Jolly MK; Maliekal TT; Prabhu JS
Cells; 2024 May; 13(10):. PubMed ID: 38786043
[TBL] [Abstract][Full Text] [Related]
6. miR-18a Mediates Immune Evasion in ER-Positive Breast Cancer through Wnt Signaling.
Nair MG; D A; M C; Vp S; Patil S; Ce A; Mukherjee G; Kumar RV; Prabhu JS; Ts S
Cells; 2022 May; 11(10):. PubMed ID: 35626709
[TBL] [Abstract][Full Text] [Related]
7. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
8. miR-18a activates Wnt pathway in ER-positive breast cancer and is associated with poor prognosis.
Nair MG; Prabhu JS; Korlimarla A; Rajarajan S; P S H; Kaul R; Alexander A; Raghavan R; B S S; T S S
Cancer Med; 2020 Aug; 9(15):5587-5597. PubMed ID: 32543775
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy.
Luengo-Gil G; García-Martínez E; Chaves-Benito A; Conesa-Zamora P; Navarro-Manzano E; González-Billalabeitia E; García-Garre E; Martínez-Carrasco A; Vicente V; Ayala de la Peña F
Cell Oncol (Dordr); 2019 Oct; 42(5):627-644. PubMed ID: 31115881
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics in Canine Mammary Tumors: Upregulation of miR-18a and miR-18b Oncogenes Is Associated with Decreased
Abbate JM; Arfuso F; Riolo K; Capparucci F; Brunetti B; Lanteri G
Animals (Basel); 2023 Mar; 13(6):. PubMed ID: 36978627
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
13. microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration.
Fonseca-Sanchéz MA; Pérez-Plasencia C; Fernández-Retana J; Arechaga-Ocampo E; Marchat LA; Rodríguez-Cuevas S; Bautista-Piña V; Arellano-Anaya ZE; Flores-Pérez A; Diaz-Chávez J; López-Camarillo C
Oncol Rep; 2013 Nov; 30(5):2399-410. PubMed ID: 23970382
[TBL] [Abstract][Full Text] [Related]
14. The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.
Waks AG; Stover DG; Guerriero JL; Dillon D; Barry WT; Gjini E; Hartl C; Lo W; Savoie J; Brock J; Wesolowski R; Li Z; Damicis A; Philips AV; Wu Y; Yang F; Sullivan A; Danaher P; Brauer HA; Osmani W; Lipschitz M; Hoadley KA; Goldberg M; Perou CM; Rodig S; Winer EP; Krop IE; Mittendorf EA; Tolaney SM
Clin Cancer Res; 2019 Aug; 25(15):4644-4655. PubMed ID: 31061067
[TBL] [Abstract][Full Text] [Related]
15. Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.
Sjöberg E; Augsten M; Bergh J; Jirström K; Östman A
Br J Cancer; 2016 May; 114(10):1117-24. PubMed ID: 27115465
[TBL] [Abstract][Full Text] [Related]
16. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
Cizeron-Clairac G; Lallemand F; Vacher S; Lidereau R; Bieche I; Callens C
BMC Cancer; 2015 Jul; 15():499. PubMed ID: 26141719
[TBL] [Abstract][Full Text] [Related]
17. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
18. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-18a and miR-210 in Normal Breast Tissue as Candidate Biomarkers of Breast Cancer Risk.
Shidfar A; Costa FF; Scholtens D; Bischof JM; Sullivan ME; Ivancic DZ; Vanin EF; Soares MB; Wang J; Khan SA
Cancer Prev Res (Phila); 2017 Jan; 10(1):89-97. PubMed ID: 27789587
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop.
Li X; Wu Y; Liu A; Tang X
Tumour Biol; 2016 Nov; 37(11):14733-14743. PubMed ID: 27629141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
